Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryden

Showing results (271-280 of 287) with videos related to

Pageof 29
Sort By:
Circulation|March 29, 2018
Regulatory CD4<sup>+</sup> T Cells Recognize Major Histocompatibility Complex Class II Molecule-Restricted Peptide Epitopes of Apolipoprotein BTakayuki Kimura, Kouji Kobiyama, Holger Winkels, et al.
Veterinary and Comparative Oncology|December 6, 2023
Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potentialSharadha Sakthikumar, Manisha Warrier, Derick Whitley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute WorkshopPaul G Kluetz, Bindu Kanapuru, Steven Lemery, et al.
Science Translational Medicine|August 31, 2018
Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeabilityAndrew J King, Matthew Siegel, Ying He, et al.
Cardiovascular Diabetology|March 17, 2023
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
Lancet (London, England)|November 15, 2017
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trialSonia S Anand, Jackie Bosch, John W Eikelboom, et al.
Stroke|September 21, 2020
Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI SubstudyMukul Sharma, Robert G Hart, Eric E Smith, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 31, 2018
Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trialMukul Sharma, Robert G Hart, Eric E Smith, et al.
European Journal of Preventive Cardiology|August 12, 2025
International patterns in lipid management and implications for patients with coronary heart disease: results from the INTERASPIRE studyJulia Brandts, Fotios Barkas, Dirk De Bacquer, et al.
Global Heart|September 8, 2025
Cardiac Rehabilitation in Patients with Coronary Heart Disease - Provision, Attendance, and Outcomes: Results from the INTERASPIRE Survey from Fourteen Countries Across Six WHO RegionsKornelia Kotseva, Dirk De Bacquer, Catriona Jennings, et al.
Pageof 29

Showing results (271-280 of 287) with videos related to

Sort By:
Pageof 29
Circulation|March 29, 2018
Regulatory CD4<sup>+</sup> T Cells Recognize Major Histocompatibility Complex Class II Molecule-Restricted Peptide Epitopes of Apolipoprotein BTakayuki Kimura, Kouji Kobiyama, Holger Winkels, et al.
Veterinary and Comparative Oncology|December 6, 2023
Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potentialSharadha Sakthikumar, Manisha Warrier, Derick Whitley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute WorkshopPaul G Kluetz, Bindu Kanapuru, Steven Lemery, et al.
Science Translational Medicine|August 31, 2018
Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeabilityAndrew J King, Matthew Siegel, Ying He, et al.
Cardiovascular Diabetology|March 17, 2023
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
Lancet (London, England)|November 15, 2017
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trialSonia S Anand, Jackie Bosch, John W Eikelboom, et al.
Stroke|September 21, 2020
Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI SubstudyMukul Sharma, Robert G Hart, Eric E Smith, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 31, 2018
Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trialMukul Sharma, Robert G Hart, Eric E Smith, et al.
European Journal of Preventive Cardiology|August 12, 2025
International patterns in lipid management and implications for patients with coronary heart disease: results from the INTERASPIRE studyJulia Brandts, Fotios Barkas, Dirk De Bacquer, et al.
Global Heart|September 8, 2025
Cardiac Rehabilitation in Patients with Coronary Heart Disease - Provision, Attendance, and Outcomes: Results from the INTERASPIRE Survey from Fourteen Countries Across Six WHO RegionsKornelia Kotseva, Dirk De Bacquer, Catriona Jennings, et al.
Pageof 29